AI applications & software · Industry Index 8 (rank #165) · $5.3B — Series E, 2025-06 — $300M at a reported $5.3B post-money valuation, investors incl. a16z, Khosla, NVIDIA Ventures and CVS Health Ventureseditorial estimate
ⓘ Data freshness
price: no data index: as of 2026-10-29 fundamentals: no data No structured SEC filings
Deep funding / news coverage runs mega-caps first — Abridge is in the graph, but detailed data isn't ingested yet.
Ambient clinical AI for health systems. Turns the patient encounter into billable documentation across 55+ specialties and 28+ languages, spanning pre-visit prep, in-visit decision support, note generation and billing-code assignment. In use at 300+ health systems.
Industry exposure 1.0 (Pure-play AI application: the product is model-generated clinical documentation.)
Signal
signal: no data
Not scored (private). Abridge is a private company, so its directional signal is not published.
Relationship network
Loading relationship graph…
NVIDIA — supplier
Key relationships
NVIDIA — supplier · Abridge's clinical-conversation foundation model is built on NVIDIA Nemotron and trained on NVIDIA Blackwell infrastructure. source: abridge.com
Unusual options activity needs a US-listed instrument; this company has none.
Not scored (private)
We don’t publish a directional call for private companies.
No moat profile yet. The durable competitive advantage — moat, leadership, and pricing power — is curated for flagship names first; Abridge isn't covered yet. Nothing here is fabricated in its absence.
Signal contribution
The moat prior — a subjective, non-backtested editorial input — only nudges the long (~6-month) horizon, and it isn't scoring Abridge yet (directional scores are withheld for private companies). Nothing here is fabricated in its absence.
2 owns · 2 partial · 1 unknown of 5 — a pattern, not a score
Owns the enterprise relationship and the whole encounter-to-billing chain at 300+ health systems, but the corpus belongs to those customers and the model is an adaptation of a third-party base. Evals are undocumented — notable for a product whose output enters the medical record.
Contracts with the health system itself — Northwell Health, the largest not-for-profit system in the Northeast, across 28 hospitals and 1,000+ outpatient facilities — rather than selling seats to individual clinicians; 300+ health systems in total. source: abridge.com
Trains on "de-identified data" from roughly 100 million conversations a year, but no proprietary corpus or exclusive right to it is described — the conversations originate in customer health systems, so the volume is real while the ownership is not established. source: abridge.com
Looked for a published validation methodology, an accuracy benchmark or a model card and found none; the cited evidence of quality is a KLAS market-survey ranking, which measures customer sentiment rather than clinical accuracy. Absence of evidence, not evidence of absence. source: abridge.com
The chain from encounter to billable record runs inside the product — pre-visit preparation, in-visit documentation and decision support, post-visit note generation, billing-code assignment, nurse documentation and clinical-trial screening, across 55+ specialties and 28+ languages. source: abridge.com
Building a foundation model for clinical conversations on NVIDIA Nemotron, trained on NVIDIA Blackwell infrastructure — the Nemotron base layer is a third party's open model and Abridge's adaptation sits on top, so the weights are customised rather than owned end to end. source: abridge.com
Abridge is live at more than 300 health systems and supports over 100 million clinical conversations a year, at partners collectively serving roughly 250 million patients, with note generation in 28-plus languages. Named enterprise deployments include Northwestern Medicine, Johns Hopkins Health System, Emory Healthcare, UCHealth and Sutter Health, where 78% of clinicians report improved work satisfaction — daily encounter workflow, not an occasional assist. At Reid Health, nursing use accompanied a vacancy rate falling from 18% to 8.6% and a 70% cut in incidental overtime. The June 2026 platform launch extends the same ambient capture beyond ambulatory documentation into nursing, inpatient and revenue-cycle workflows, surfaces it had only begun to address. source: abridge.com
A paired axis, not a sixth band: it is never counted in the pattern above and the two are never averaged into one score.
customer: In active use at 300+ health systems, supporting roughly 100 million conversations annually across patient populations totalling 250M+. (300+ health systems) 2026-08-05source: abridge.com
customer: Northwell Health deployment across 28 hospitals and more than 1,000 outpatient facilities, alongside one of the largest Epic EHR implementations in the country. (28 hospitals) 2026-08-05source: abridge.com
Scouted against the condition: a company that simultaneously owns the customer relationship, the data, the evals, the workflow, and a domain-specific model. Weightless — this profile never affects a signal, and it is not a forecast of returns.
No structured SEC filings. Abridge does not file XBRL with the SEC; see funding rounds under Investors.
Funding rounds
No recorded funding rounds.
Headline valuation: $5.3B — Series E, 2025-06 — $300M at a reported $5.3B post-money valuation, investors incl. a16z, Khosla, NVIDIA Ventures and CVS Health Ventures editorial estimate
